The inducible nitric oxide synthase-inhibitor 1400W as a potential treatment for retinal diseases
Sven Schnichels*, Stephanie C. Joachim
University Eye Hospital Tübingen, Centre for Ophthalmology, Tübingen, Germany (Schnichels S)
Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Bochum, Germany (Joachim SC)
Online:2021-06-15
Published:2020-12-31
Contact:
Sven Schnichels, PhD,sven.schnichels@med.uni-tuebingen.de.
Supported by:
We thank all the collaborators and coauthors who thereby contributed to this perspective article, especially José Hurst and Ana Mueller-Buehl. We also thank Sami Ullah and Teresa Tsai for their support concerning the figures as well as for critical proof reading.
This work was supported in part by the set Stiftung.
Sven Schnichels, Stephanie C. Joachim. The inducible nitric oxide synthase-inhibitor 1400W as a potential treatment for retinal diseases[J]. Neural Regeneration Research, 2021, 16(6): 1221-1222.